Evaluation of diagnostic potential of immunoreactive epitopes of the Omptin protease family by using a peptide library

The construction of highly sensitive new-generation diagnostic test systems requires the use of modern innovative technologies that are capable of detecting infectious agents at the molecular level by identifying specific antibodies to individual immunoreactive epitopes. The development of such immunoassays is based on molecular mapping of a target antigen using a library of short overlapping peptides aimed at identification of both epitopes specific for a particular pathogen, and those common to the group of infectious agents. The article describes new approaches that are based on the results of mapping of the Omptin group model protein that could be critical for improving retrospective laboratory diagnosis of infectious diseases caused by bacteria of the Enterobacteriaceae family. The article discusses the prospects for assessing the applicability of the peptide ELISA experimental version, designated as p6/24-Omptin-TIFA, for the detection of antibodies to diagnostically significant Omptin epitopes in the serum of people who have had enterobacterial infections, in order to introduce it into healthcare practices.

лабораторная диагностика, пептидный эррей, твердофазный иммуноферментный анализ, Omptin, Enterobacteriaceae, ретроспективная диагностика, иммунореактивный эпитоп, laboratory diagnosis, peptide array, ELISA, Omptin, Enterobacteriaceae, retrospective diagnosis, immunoreactive epitope

1. Zabokritskiy NA. The infectious morbidity in the Russian Federation and tendencies of it is development in the next decade. On-line Scientific & Educational Bulletin «Health and Education Millennium». 2015; 17(5): 16–26 (in Russian).

2. Rospotrebnadzor released statistics of infectious diseases for the first half of the year. Available from: http://www.yaprivit.ru/ news/2365/.

3. Reineke U, Schutkowski M, eds. Methods of Molecular Biology, Epitope Mapping Protocols. Vol. 524. New York: Humana Press; 2009.

4. Hritonenko V, Stathopoulos C. Omptin proteins: an expanding family of outer membrane proteases in Gram-negative Enterobacteriaceae. Mol Membr Biol. 2007; 24(5 – 6): 395–406.

5. Kukkonen M, Korhonen TK. The Omptin family of enterobacterial surface proteases/adhesins: from housekeeping in Escherichia coli to systemic spread of Yersinia pestis. Int J Med Microbiol. 2004; 294(1): 7–14.

6. Haiko J, Suomalainen M, Ojala T, Lähteenmäki K, Korhonen TK. Invited review: Breaking barriers – attack on innate immune defences by Omptin surface proteases of enterobacterial pathogens. Innate Immun. 2009; 15(2): 67–80.

7. Brannon JR, Thomassin JL, Gruenheid S, Le Moual H. Antimicrobial peptide conformation as a structural determinant of Omptin protease specificity. J Bacteriol. 2015; 197(22): 3583–91.

8. Sodeinde OA, Subrahmanyam YV, Stark K, Quan T, Bao Y, Goguen JD. A surface protease and the invasive character of plague. Science 1992; 258(5084): 1004–7.

9. Kukleva LM, Boiko AV. Plasminogen activator — multifunctional protein of plague pathogen. Problems of Particularly Dangerous Infections 2016; 3: 13–20 (in Russian).

10. Korhonen TK, Haiko J, Laakkonen L, Järvinen HM, Westerlund-Wikström B. Fibrinolytic and coagulative activities of Yersinia pestis. Front Cell Infect Microbiol. 2013; 3: 35.

11. Evseeva VV, Platonov ME, Kopylov PKh, Dentovskaya SV, Anisimov AP. Plasminogen activator of Yersinia pestis. Russian Journal of Infection and Immunity 2015; 5(1): 27–36 (in Russian).

12. Easterbrook TJ, Reddin K, Robinson A, Modi N. Studies on the immunogenicity of the Pla protein from Yersinia pestis. Contrib Microbiol Immunol. 1995; 13: 214–5.

13. Benner GE, Andrews GP, Byrne WR, Strachan SD, Sample AK, Heath DG, et al. Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice. Infect Immun. 1999; 67(4):1922–8.

14. Feodorova VA, Devdariani ZL. Development, characterisation and diagnostic application of monoclonal antibodies against Yersinia pestis fibrinolysin and coagulase. J Med Microbiol. 2000; 49(3): 261–9.

15. Braciale VL, Nash M, Sinha N, Zudina IV, Motin VL. Correlates of immunity elicited by live Yersinia pestis vaccine. In: Georgiev VS, Western K, McGowan JJ, eds. National Institute of Allergy and Infectious Diseases, NIH. Volume 1: Frontiers in Research. Totowa, NJ: Humana Press; 2008. P. 473–80.

16. Feodorova VA, Khizhnyakova MA, Lyapina AM, Zaitsev SS, Telepnev MV, Sayapina LV, et al. Murine and human early humoral immune responses to Yersinia pestis Pla antigen followed by immunization with live plague vaccine: Proceeding Book of the 12th International Yersinia Symposium. 2016, Oct. 25–28; Tbilisi; Georgia. P. 38.

17. Yersinia pestis CO92 plasmid pPCP1, complete sequence. NCBI Reference Sequence: NC 003132.1. Available from: https://goo.gl/ 26Ag6J.

18. Heuzenroeder MW, Barton MD, Vanniasinkam T, Phumoonna T. Linear B-cell epitope mapping using enzyme-linked immunosorbent assay for libraries of overlapping synthetic peptides. Methods Mol Biol. 2009; 524: 137–44.

19. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0. Mol Biol Evol. 2013; 30(12): 2725–9.

20. Khizhnyakova MA, Feodorova VA, Zaitsev SS, Motin VL. The use of peptide microchips for epitope carting and immuno-diagnostics of infectious diseases. Izvestia Orenburg State Agrarian University 2013; 1(39): 228–30 (in Russian).